NCT02477462View on ClinicalTrials.gov

Identification of Inflammatory and Fibrotic Biomarkers in PBC and NAFLD Patients

CompletedOBSERVATIONAL
Enrollment

124

Participants

Timeline

Start Date

May 31, 2015

Primary Completion Date

June 6, 2019

Study Completion Date

June 6, 2019

Conditions
Primary Biliary Cirrhosis
Interventions
OTHER

Clinic visit

Blood draw every 3 months; quality of life surveys and imaging annually

OTHER

Baseline visit

Blood draw and quality of life surveys

Trial Locations (1)

95817

University of California Davis Medical Center, Sacramento

All Listed Sponsors
lead

University of California, Davis

OTHER

NCT02477462 - Identification of Inflammatory and Fibrotic Biomarkers in PBC and NAFLD Patients | Biotech Hunter | Biotech Hunter